TrialA Study to Evaluate LB1148 for Return of Bowel Function in Subjects Undergoing Bowel Resection
Trial details
- Registry ID
- NCT05470387
- Phase
- Phase 3
Drug research
LB1148
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
Also recorded as Active
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study to Evaluate LB1148 for Return of Bowel Function in Subjects Undergoing Bowel ResectionNCT05470387 | Palisade Bio | Phase 3 | Terminated | 2023-03-06Actual |
| A Study to Evaluate LB1148 for Return of Gastrointestinal Function and Adhesions in Subjects Undergoing Bowel ResectionNCT02836470 | Palisade Bio | Phase 2 | Completed | 2023-09-06Actual |
A Study to Evaluate LB1148 for Return of Gastrointestinal Function and Adhesions in Subjects Undergoing Bowel Resection
Trial details
- Registry ID
- NCT02836470
- Phase
- Phase 2
Regulatory dates and decisions
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |